Oleic acid acutely impairs glucose homeostasis in standard chow diet but not high-fructose, high-fat diet-fed mice by acting on free fatty acid receptor 1
DOI:
https://doi.org/10.1590/Keywords:
OA, GW1100, FFAR1, Glucose tolerance, High-fructose, High-fat diet, Insulin resistanceAbstract
This study aimed to investigate the acute effects of oleic acid (OA) on glucose homeostasis in mice fed a standard chow diet (SCD) and a high-fructose, high-fat diet (HFrHFD); moreover, the role of free fatty acid receptor 1 (FFAR1) was evaluated. The mice in the two groups were further divided into three subgroups as follows: control, OA (40 mg/kg), and OA + GW1100 (0.4 mg/kg, selective FFAR1 blocker). After a 16-week feeding period, the mice received the drugs via intraperitoneal (i.p.) injection followed by an i.p. glucose tolerance test (IPGTT) 30 min later. After 3 days, the mice received the same drugs to examine the effects of the drugs on the hepatic levels of phosphatidylinositol-4,5-bisphosphate (PIP2) and diacylglycerol (DAG). OA in the SCD-fed mice significantly increased the blood glucose level (48%, P < 0.001) after 30 min of glucose load compared to that in the control group, but did not affect the levels of PIP2 and DAG. Pre-injection with GW1100 significantly decreased the area under the curve of the IPGTT (28%, P < 0.05) in the SCD group compared to that in the SCD + OA group. OA reduced the blood glucose level (35%, P < 0.001) after 120 min of glucose load in the HFrHFD-fed mice; in addition, it increased hepatic PIP2 (160%, P < 0.01) and decreased hepatic DAG (60%, P < 0.001) levels. Pre-injection with GW1100 blocked the effects of OA on hepatic PIP2 and DAG without affecting the glucose tolerance. In conclusion, OA acutely impaired the glucose tolerance in the SCD-fed mice by acting on FFAR1 but did not improve it in the HFrHFD-fed mice.
Downloads
References
Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007;30(1):89-94.
Cai J, Abramovici H, Gee SH, Topham MK. Diacylglycerol kinases as sources of phosphatidic acid. Biochim Biophys Acta. 2009;1791(9):942-948.
Cornall LM, Mathai ML, Hryciw DH, McAinch AJ. Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner. Cell Physiol Biochem. 2011;28(5):949-958.
Deisl C, Anderegg M, Albano G, Lüscher BP, Cerny D, Soria R et al. Loss of sodium/hydrogen exchanger NHA2 exacerbates obesity-and aging-induced glucose intolerance in mice. PLoS One. 2016;11(9):e0163568.
El-Fayoumi SH, Mahmoud AAA, Fahmy A, Ibrahim IAAE. Effect of omega-3 fatty acids on glucose homeostasis: role of free fatty acid receptor 1. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(10):1797-1808.
Ferdaoussi M, Bergeron V, Zarrouki B, Kolic J, Cantley J, Fielitz J et al. G protein-coupled receptor (GPR) 40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1. Diabetologia. 2012;55(10):2682-2692.
Gonçalves de Albuquerque CF, Burth P, Younes Ibrahim M, Garcia DG, Bozza PT, Castro Faria Neto HC et al. Reduced plasma nonesterified fatty acid levels and the advent of an acute lung injury in mice after intravenous or enteral oleic acid administration. Mediators Inflamm. 2012;2012:601032.
Hansen HS, Rosenkilde MM, Holst JJ, Schwartz TW. GPR119 as a fat sensor. Trends Pharmacol Sci. 2012;33(7):374-381.
Ibrahim IA, Nakaya M, Kurose H. Ezrin, radixin, and moesin phosphorylation in NIH3T3 cells revealed angiotensin II type 1 receptor cell-type-dependent biased signaling. J Pharmacol Sci. 2013;122(1):1-9.
Ibrahim WS, Ibrahim IAAE, Mahmoud MF, Mahmoud AAA. Carvedilol diminishes cardiac remodeling induced by high-fructose/high-fat diet in mice via enhancing cardiac β-arrestin2 signaling. J Cardiovasc Pharmacol Ther. 2020;25(4):354-363.
Im DS. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation. Mol Aspects Med. 2018;64:92-108.
Jensen TL, Kiersgaard MK, Sørensen DB, Mikkelsen LF. Fasting of mice: a review. Lab Anim. 2013;47(4):225-240.
Jornayvaz FR, Shulman GI. Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metabol. 2012;15(5):574-584.
Kaji I, Karaki SI, Tanaka R, Kuwahara A. Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide. J Mol Histol. 2011;42(1):27-38.
Kim J, Okla M, Erickson A, Carr T, Natarajan SK, Chung S. Eicosapentaenoic acid potentiates brown thermogenesis through FFAR4-dependent up-regulation of miR-30b and miR-378. J Biol Chem. 2016;291(39):20551-20562.
López Soto EJ, Gambino LO, Mustafá ER. Free fatty acid receptor 3 is a key target of short chain fatty acid: what is the impact on the sympathetic nervous system?. Channels. 2014;8(3):169-171.
Luan B, Zhao J, Wu H, Duan B, Shu G, Wang X, et al. Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance. Nature. 2009;457(7233):1146-1149.
Mansour R, Ibrahim I, Elfayoumy H, Ahmed A. Oleic acid antagonizes the action of high fructose high fat diet on insulin secretion and adipose tissue β-arrestin signaling. Zagazig J Pharm Sci. 2019;28(1):1-2.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia . 1985;28(7): 412-419.
Miyamoto J, Hasegawa S, Kasubuchi M, Ichimura A, Nakajima A, Kimura I. Nutritional signaling via free fatty acid receptors. Int J Mol Sci. 2016;17(4):450.
Moniri NH. Free-fatty acid receptor-4 (GPR120): cellular and molecular function and its role in metabolic disorders. Biochem Pharmacol. 2016;110-111:1-15.
Nakamoto K, Nishinaka T, Sato N, Mankura M, Koyama Y, Kasuya F et al. Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain. PLoS One . 2013;8(12):e81563.
Nelson CD, Kovacs JJ, Nobles KN, Whalen EJ, Lefkowitz RJ. β-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Iα promotes agonist-stimulated sequestration of the β2-adrenergic receptor. J Biol Chem . 2008;283(30):21093- 21101.
Nuber S, Zabel U, Lorenz K, Nuber A, Milligan G, Tobin AB et al. β-arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle. Nature . 2016;531(7596):661-664.
Orsavova J, Misurcova L, Ambrozova JV, Vicha R, Mlcek J. Fatty acids composition of vegetable oils and its contribution to dietary energy intake and dependence of cardiovascular mortality on dietary intake of fatty acids. Int J Mol Sci . 2015;16(6):12871-12890.
Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V et al. High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57(1):51-64.
Salehi A, Flodgren E, Nilsson NE, Jimenez-Feltstrom J, Miyazaki J, Owman C, Olde B. Free fatty acid receptor 1 (FFA 1 R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res. 2005;322(2):207-215.
Schnell S, Schaefer M, Schöfl C. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from β-cells through activation of GPR40. Mol Cell Endocrinol. 2007;263(1-2):173-180.
Shen X, Yang L, Yan S, Wei W, Liang L, Zheng H et al. The effect of FFAR1 on pioglitazone-mediated attenuation of palmitic acid-induced oxidative stress and apoptosis in βTC6 cells. Metabolism. 2014;63(3):335-351.
Tsuchiya A, Nagaya H, Kanno T, Nishizaki T. Oleic acid stimulates glucose uptake into adipocytes by enhancing insulin receptor signaling. J Pharmacol Sci . 2014;126(4):337-343.
Vassiliou EK, Gonzalez A, Garcia C, Tadros JH, Chakraborty G, Toney JH. Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-α both in vitro and in vivo systems. Lipids Health Dis. 2009;8:25.
Vidyashankar S, Varma RS, Patki PS. Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. Toxicol In Vitro. 2013;27(2):945-953.
Wang J, Wu X, Simonavicius N, Tian H, Ling L. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem . 2006;281(45):34457-34464.
Wootten D, Christopoulos A, Marti-Solano M, Babu MM, Sexton PM. Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat Rev Mol Cell Biol. 2018;19(10):638-653.
Yamada H, Yoshida M, Ito K, Dezaki K, Yada T, Ishikawa SE et al. Potentiation of glucose-stimulated insulin secretion by the GPR40-PLC-TRPC pathway in pancreatic β-cells. Sci Rep. 2016;6:25912.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
